Mediagnost is active in research in various areas of biotechnology. The main focus is on the further development of vaccines against hepatitis A and the development of test kits in the field of endocrinology, in particular for the detection of growth disorders. Research activities also focus on the development of new test methods for the early detection of neurological diseases and sepsis.

Since most of the detection methods used are based on antigen-antibody reactions, the available expertise in the development and production of monoclonal and polyclonal antibodies against corresponding proteins is of great importance. Mediagnost is also highly specialized in large-scale cell culture cultivation and has many years of experience in nucleic acid technology.

Mediagnost supervises bachelor and master theses (